Andere Kunden interessierten sich auch für
![Genetic profiling of CYP2D6 variants known to alter enzyme activity]( "Genetic profiling of CYP2D6 variants known to alter enzyme activity")
Genetic profiling of CYP2D6 variants known to alter enzyme activity32,99 €![Nexus of Metabolic Syndrome and Periodontal disease]( "Nexus of Metabolic Syndrome and Periodontal disease")
Nexus of Metabolic Syndrome and Periodontal disease36,99 €![Metabolic Syndrome (MetS)]( "Metabolic Syndrome (MetS)")
Metabolic Syndrome (MetS)55,99 €![Electroneurographic parameters in patients with metabolic syndrome]( "Electroneurographic parameters in patients with metabolic syndrome")
Electroneurographic parameters in patients with metabolic syndrome16,99 €![Prevalence and Characteristic Features of Metabolic Syndrome]( "Prevalence and Characteristic Features of Metabolic Syndrome")
Prevalence and Characteristic Features of Metabolic Syndrome38,99 €![Metabolic Syndrome]( "Metabolic Syndrome")
Metabolic Syndrome32,99 €![Angiographic profile of NSTEMI patient with/without metabolic syndrome]( "Angiographic profile of NSTEMI patient with/without metabolic syndrome")
Angiographic profile of NSTEMI patient with/without metabolic syndrome32,99 €
Metabolic syndrome is a modern era disease which has engulfed wide regions of the world and the problem is increasing at a rapid pace. The atherogenic dyslipidemia associated with the metabolic syndrome predispose to cardiovascular events. The Statins are considered first-line therapy for treating Dyslipidemia. Clinical response to statins is highly variable and genetic factors play an important role. Sterol regulatory element binding factors (SREBF) SREBF Cleavage Activating Protein (SCAP) pathway play important roles in lipid metabolism and homeostasis. Identification of genes & genetic variants that influence statin responsiveness holds promise for a safe and effective treatment of Dyslipidemia in Metabolic syndrome.